gestational%20diabetes%20mellitus
GESTATIONAL DIABETES MELLITUS
Gestational diabetes mellitus (GDM) is any degree of glucose intolerance with onset or first recognition during pregnancy.
Hyperglycemia in pregnancy may be suggested by the presence of glycosuria, a fetus that is large for date, or polyhydramnios.
Overt diabetes mellitus may be found in women presenting with risk factors for type 2 diabetes during the first prenatal visit (before 13 weeks of gestation).

Introduction

Gestational Diabetes Mellitus (GDM)
  • Any degree of glucose intolerance with onset or first recognition during pregnancy 
    • It is diabetes that is first diagnosed in the 2nd or 3rd trimester of pregnancy that has not been a pre-existing type 1 or 2 diabetes  
  • Hyperglycemia in pregnancy may be suggested by the presence of glycosuria, a fetus that is large for date, or polyhydramnios  
  • Prevalence of GDM appears to be high in South Asia and South East Asian women compared to African-American, Caucasian and Hispanic women; prevalence rates are 3-21.2% in women with GDM who were born in Asian countries  
    • Rates of fetal macrosomia are lower in South East Asian women than in American Caucasian women  
    • Asian women with GDM have a higher incidence of abnormal postpartum glucose tolerance tests and risk of developing type 2 DM in the future is higher than in Anglo-European women
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
22 Apr 2016
Painful diabetic neuropathy (PDN) is one of the many complications of diabetes. At the Diabetes Asia 2015 Conference, renowned speaker Dr Mary Cardosa gave an overview on PDN and the approaches to managing this condition.
16 Jul 2017
Nonalcoholic fatty liver diseases (NAFLD) and serum concentrations of alanine transaminase (ALT), aspartate transaminase (AST), gamma-glutamyltransferase (GGT) and alkaline phosphatase (ALP) are independent predictors of incident type 2 diabetes, a new prospective study shows.
02 Nov 2015
Long-term pegvisomant treatment enhances cardiac and respiratory comorbidities in acromegalic patients based on a retrospective single-centre study.
07 Apr 2016
Pioglitazone reduces risk for stroke or myocardial infaction (MI) in patients with history of ischaemic stroke or transient ischaemic attack (TIA), based on a multicentre, double-blind trial.